1. 国家自然基金青年基金、81302502、 miR-143基因启动子区遗传变异影响基因转录调控区机制及与宫颈癌发生危险性的研究、2014/01-2016/12、23万元、结题、项目参与者

2. 国家自然基金青年基金、81502243、子宫内膜腺癌分化的新机制：同源盒基因HOXA10的功能研究、2014/01-2016/12、23万元、结题、项目参与者

3. 江苏省自然科学青年基金项目、BK20130641、miR21基因启动子区多态变异与宫颈癌遗传易感性及其机制探讨、2013/07-2016/06、20万元、结题、项目参与者

4. 江苏省卫生厅、F201351、miR-497 通过调控FASN/PI3K/AKT信号通路影响卵巢癌发生的新机制研究 2013/01—2016/12、15万元、结题、项目负责人

5. 国家自然基金面上项目、30973475、PI3K/AKT通路介导FASN与HER2的相互作用调控大肠癌恶性表型及其分子机制研究 2010/01—2012/12、32万元、结题、项目第二负责人

1.Ji X, Yang Q, Zhu XL, Xu L, Guo JY, Rong Y, Cai YL.

 Association between gut microbiota and endometriosis: a two-sample Mendelian randomization study. Front Microbiol. 2023 Sep 27;14:1188458. doi: 10.3389/fmicb.2023.1188458.

2.Xu H, Zhao F, Wu D, Zhang Y, Bao X, Shi F, Cai Y, Dou J. 

Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination. Biomed Pharmacother. 2023 May;161:114547.

3.Feng J, Tang D, Wang J, Zhou Q, Peng J, Lou H, Sun Y, Cai Y, Chen H, Yang J, Liu P, Wang L, Zou J. 

SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study. Clin Cancer Res. 2022 Dec 15;28(24):5297-5305.

4.Sun X, Wang X, Yan C, Zheng S, Gao R, Huang F, Wei Y, Wen Z, Chen Y, Zhou X, Liu X, Chen B, Shen Y, Cai Y, Pan N, Wang L. 

Tumor cell-released LC3-positive EVs promote lung metastasis of breast cancer through enhancing premetastatic niche formation. Cancer Sci. 2022 Oct;113(10):3405-3416.

5.Zhu XL, Wang HJ, Wang XR, Wu D, Ji X, Xu L, Yang Q, Guo JY, Rong Y, Pan N, Cai YL. 

IL-6 secretion of CD4⁺ T cells stimulated by LC3-positive extracellular vesicles in human epithelial ovarian cancer. Clin Transl Oncol. 2022 Nov;24(11):2222-2230. 

6.Xiaocui L, Wei H, Yunlang C, Zhenzhen Z, Min A. 

CSF-1-induced DC-SIGN⁺ macrophages are present in the ovarian endometriosis. Reprod Biol Endocrinol. 2022 Mar 8;20(1):48. 

7.Li X, Li H, Shi H, Li X, Zhou R, Lu D, Cai Y, Zhou Y, Cabri P, Shi X, Pedret-Dunn A, Leng J.

 Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial. Adv Ther. 2022 Oct;39(10):4663-4677.

8.Shi T, Zhu J, Feng Y, Tu D, Zhang Y, Zhang P, Jia H, Huang X, Cai Y, Yin S, Jiang R, Tian W, Gao W, Liu J, Yang H, Cheng X, Zang R.

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2021 Apr;22(4):439-449. doi: 10.1016/S1470-2045(21)00006-1. Epub 2021 Mar 8. 

9.Chen YQ, Li PC, Pan N, Gao R, Wen ZF, Zhang TY, Huang F, Wu FY, Ou XL, Zhang JP, Zhu XJ, Hu HM, Chen K, Cai YL, Wang LX. 

Tumor-released autophagosomes induces CD4⁺ T cell-mediated immunosuppression via a TLR2-IL-6 cascade. J Immunother Cancer. 2019 Jul 12;7(1):178. 

10.Cai Y, Wu F, Yu Y, Liu Y, Shao C, Gu H, Li M, Zhao Y. 

Porous scaffolds from droplet microfluidics for prevention of intrauterine adhesion. Acta Biomater. 2019 Jan 15;84:222-230.